PRVB
Provention Bio, Inc. Common Stock
PRVB
PRVB
Delisted
PRVB was delisted on the 26th of April, 2023.
106 hedge funds and large institutions have $378M invested in Provention Bio, Inc. Common Stock in 2020 Q4 according to their latest regulatory filings, with 17 funds opening new positions, 34 increasing their positions, 35 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
53% less call options, than puts
Call options by funds: $1.11M | Put options by funds: $2.35M
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
106
Holding in Top 10
–
Calls
$1.11M
Puts
$2.35M
Top Buyers
| 1 | +$10.4M | |
| 2 | +$3.53M | |
| 3 | +$3.53M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.43M |
| 5 |
Squarepoint
New York
|
+$1.31M |
Top Sellers
| 1 | -$7.38M | |
| 2 | -$2.74M | |
| 3 | -$2.28M | |
| 4 |
MWNA
Marshall Wace North America
New York
|
-$1.17M |
| 5 |
Goldman Sachs
New York
|
-$1.03M |